---
title: 'DLBclass: A Probabilistic Molecular Classifier to Guide Clinical Investigation
  and Practice in DLBCL'
date: '2024-12-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39680847/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241217170847&v=2.18.0.post9+e462414
source: Blood
description: Diffuse large B-cell lymphoma (DLBCL) is a clinically and molecularly
  heterogeneous disease. The increasing recognition and targeting of genetically defined
  DLBCLs highlights the need for robust classification algorithms. We previously characterized
  recurrent genetic alterations in DLBCL and identified five discrete subtypes, Clusters
  1-5 (C1-C5), with unique mechanisms of transformation, immune evasion, candidate
  treatment targets and different outcomes following standard first-line ...
disable_comments: true
---
Diffuse large B-cell lymphoma (DLBCL) is a clinically and molecularly heterogeneous disease. The increasing recognition and targeting of genetically defined DLBCLs highlights the need for robust classification algorithms. We previously characterized recurrent genetic alterations in DLBCL and identified five discrete subtypes, Clusters 1-5 (C1-C5), with unique mechanisms of transformation, immune evasion, candidate treatment targets and different outcomes following standard first-line ...